AstraZeneca, Handa agree to pay $5.47 million to resolve US antitrust claims over Seroquel XR
MLex Summary: AstraZeneca and Handa Pharmaceuticals agreed to pay $5.47 million to resolve end-payors' US antitrust claims over the drug Seroquel XR. If approved, AstraZeneca will pay $5 million and Handa will...To view the full article, register now.
Already a subscriber? Click here to view full article